NCT02334345View on ClinicalTrials.gov

Skin Protection During Radiotherapy in Patients With Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 1, 2015

Study Completion Date

January 17, 2021

Conditions
Radiation Dermatitis
Interventions
DRUG

Evoskin

Evoskin is Trixiera is a topical agent recommended to help patients in the management of radiation skin reactions

DRUG

Trixiera

Trixiera is a topical agent recommended to help patients in the management of radiation skin reactions

Trial Locations (1)

87000

CHU LIMOGES - Radiothérapie, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT02334345 - Skin Protection During Radiotherapy in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter